Avelumab in G2-3 NET

Clinical trial NCT03278379 · COMPLETED

Trial details

NCT number: NCT03278379
Sponsor: Sunnybrook Health Sciences Centre
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neuroendocrine Tumors

Start date: 2017-11-15
Primary completion: 2021-07-26
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.